Novozymes A/S (ETR:NZM2)

Market Cap	27.43B +6.5%
Revenue (ttm)	4.37B +5.5%
Net Income	681.50M +24.6%
EPS	1.46 -23.8%
Shares Out	n/a
PE Ratio	40.82
Forward PE	25.17
Dividend	0.88 (1.48%)
Ex-Dividend Date	Aug 25, 2026

Volume	5
Open	60.50
Previous Close	61.42
Day's Range	59.26 - 60.50
52-Week Range	46.74 - 64.76
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About Novozymes

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; e...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1925
• Employees: 11,098
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: NZM2

Financial Performance

In 2025, Novozymes's revenue was 4.16 billion, an increase of 8.45% compared to the previous year's 3.83 billion. Earnings were 583.60 million, an increase of 90.84%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Nov 11, 2026

Data Sources Report a data error